Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedA Locations section was updated to include new study sites across multiple countries and regions (US states and international locations), and some existing location entries were removed.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a notice that publications are automatically filled from PubMed and may not be about the study. Updated the revision tag to v3.3.2, replacing the previous v3.2.0 text.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding lapse notice and the associated operating-status guidance from the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedNo significant content changes detected; minor formatting adjustments observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedThe page now communicates a funding-related operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference0.7%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.